BETHESDA, Md., Sept. 2, 2010 — The American Society for Biochemistry and Molecular Biology expressed its disapproval and disappointment this week in response to the Aug. 23 ruling in the U.S. District Court for the District of Columbia that grante…
EAST LANSING, Mich. — Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers.
The imp…
Athens, Ga. — Trypanosomes are parasites responsible for many human and animal diseases, primarily in tropical climates. One disease these parasites cause, African sleeping sickness, results from the bite of infected tsetse flies, putting over 60 …
Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity and a battered immune system.
Now, a new way to deliver this life-saving therapy to cancer patients ― getting str…
A compound developed by British scientists early in World War II as a treatment against chemical weapons has value against today’s threat of bioterrorism, according to Indiana University School of Medicine researchers at Indiana University-Purdue University Fort Wayne. Researchers studying British Anti-Lewisite provide an overview of its historical uses, development and clinical implications today of the heavy metal chelating agent, detailed in the March issue of the Annals of Emergency Medicine. BAL is a medical therapy to remove metal poisonings from the body.
A lab headed by a Saint Louis University researcher has made a major breakthrough that could lead to a better molecular understanding of cancer. Results published today in the Journal Molecular Cell by Ali Shilatifard, Ph.D., and colleagues show for the first time how a protein known to be involved in the development of cancer functions in normal cells. The research shows how the protein “Bre1” plays a pivotal role in determining how the protein “Rad6” functions in modification of chromosomal DNA. Also participating in this research was the lab of Dr. Mark Johnston at Washington University School of Medicine.